PBH is currently covered by 5 analysts with average potential upside of $7.48 (16.2%) backed by 33 price targets and 46 ratings. Documented since 18-May-2012. Analyst's average stock valuation to be materialised ratio is 62.77% with an average time for price targets to be met of 411.2 days.
Most recent stock forecast was given by RUPESH PARIKH from OPPENHEIMER on 17-Feb-2023.
Highest price target for PBH is 67, Lowest price target is 46, average price target is 56.5.
Currently, out of the existing stock ratings of PBH - 4 which are a Hold (40%), 6 which are a Buy (60%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
71
$8.34 (13.31%)
72
1 months 12 days ago
5/7 (71.43%)
$5.32 (14.93%)
155
Buy
71
$8.34 (13.31%)
4 months 12 days ago
0/1 (0%)
$12.56 (21.49%)
Buy
70
$7.34 (11.71%)
10 months 19 days ago
7/8 (87.5%)
$0.59 (1.64%)
611
Hold
70
$7.34 (11.71%)
43
10 months 19 days ago
6/7 (85.71%)
$7.1 (15.11%)
1151
Hold
60
$-2.66 (-4.25%)
63
10 months 20 days ago
9/13 (69.23%)
$11.84 (27.82%)
139
What is PBH(Prestige Consumer Healthcare Inc) average time for price targets to be met?
Which analyst has the current highest performing score on PBH(Prestige Consumer Healthcare Inc) with a proven track record?
